Is there an interest in repeating the vaginal administration of dinoprostone (Propess®), to promote induction of labor of pregnant women at term? (RE-DINO): study protocol for a randomized controlled trial

Autor: P. Coste Mazeau, M. Hessas, R. Martin, J.-L. Eyraud, F. Margueritte, Y. Aubard, C. Sallee, F. Sire, T. Gauthier

Publikováno v: Trials, Vol 21, Iss 1, Pp 1-8 (2020)

Abstract Background Labor is induced in over 20% of women in France. Prostaglandins, especially intravaginal dinoprostone (Propess®), are widely used to initiate cervical ripening. If labor does not start within 24 h, there is uncertainty about whet

Externí odkaz: https://doaj.org/article/a08315f714884e06bbab61c6e36860b3

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Results of the RE-DINO multicenter randomized trial on the repeated use of vaginal dinoprostone (Propess®) for labor induction in patients at term.

Autor: Coste-Mazeau P; Limoges Regional University Hospital, Department of Gynecology and Obstetrics, Mother and Children's Hospital, Limoges, France (Coste-Mazeau); University of Limoges, Inserm, CHU Limoges, RESINFIT, Limoges, France (Coste-Mazeau). Electronic address: perrine.coste-mazeau@unilim.fr., Gallot D; Obstetric Department, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France (Gallot)., Siegerth F; Department of Gynecology and Obstetrics, Brive Hospital Center, Brive, France (Siegerth, Cantaloube, and Hessas)., Garuchet-Bigot A; Department of Gynecology and Obstetrics, Blois Hospital Center, Blois, France (Garuchet-Bigot)., Decroisette E; Department of Obstetrics, Chambéry Hospital Center, Chambéry, France (Decroisette)., Blanc J; Department of Obstetrics and Gynecology, Nord Hospital, Assistance Publique - Hopitaux de Marseille, Marseille, France (Blanc)., Cantaloube M; Department of Gynecology and Obstetrics, Brive Hospital Center, Brive, France (Siegerth, Cantaloube, and Hessas)., Crépin S; Clinical Trials Vigilance Unit, Department of Pharmacology-Toxicology and Pharmacovigilance, Limoges Regional University Hospital, Limoges, France (Crépin); Inserm, Univ. Limoges, Pharmacology & Transplantation, Limoges, France (Crépin)., Magne J; Centre de Données Cliniques et de Recherche (CDCR), Limoges Regional University Hospital, Limoges, France (Magne and Labrunie)., Labrunie A; Centre de Données Cliniques et de Recherche (CDCR), Limoges Regional University Hospital, Limoges, France (Magne and Labrunie)., Martin R; Direction of Research and Innovation, CHRU Limoges, Limoges, France (Martin)., Hessas M; Department of Gynecology and Obstetrics, Brive Hospital Center, Brive, France (Siegerth, Cantaloube, and Hessas).

Publikováno v: American journal of obstetrics & gynecology MFM [Am J Obstet Gynecol MFM] 2024 Sep 27; Vol. 6 (11), pp. 101510. Date of Electronic Publication: 2024 Sep 27.